{"name":"Chafic Karam","slug":"chafic-karam","ticker":"","exchange":"","domain":"","description":"Chafic Karam is a biopharmaceutical company focused on the development of innovative therapies. The company has one drug in its pipeline, Efgartigimod Alfa-Fcab, which is currently discontinued.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE11RXpSTk03cXpJVEVES29mZGRwLWppbXZQc1JNUkpUVU9aZ2l1eEgwd2tjR0UxalkydXVnWFQycWpvQVdoQncwVTljY0dya2Nsay1HV2htQW41U3Rfd09ZclJZUFNvRVQ4ZVE?oc=5","date":"2024-01-04","type":"pipeline","source":"Wiley Online Library","summary":"Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts - Wiley Online Library","headline":"Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendation","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}